88 related articles for article (PubMed ID: 20477054)
1. Development of autoimmunity in lymphoma.
Jardin F
Expert Rev Clin Immunol; 2008 Mar; 4(2):247-66. PubMed ID: 20477054
[TBL] [Abstract][Full Text] [Related]
2. [Auto-immune manifestations in Non-Hodgkin's lymphoma].
Jardin F; Lévesque H; Tilly H
Rev Med Interne; 2005 Jul; 26(7):557-71. PubMed ID: 15996570
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
5. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
7. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
10. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders.
Polliack A; Lugassy G
Leukemia; 1992 Nov; 6 Suppl 4():152-4. PubMed ID: 1434818
[TBL] [Abstract][Full Text] [Related]
12. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
13. Epratuzumab in the therapy of oncological and immunological diseases.
Goldenberg DM
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1341-53. PubMed ID: 17069520
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's Syndrome.
Papiris SA; Tsonis IA; Moutsopoulos HM
Semin Respir Crit Care Med; 2007 Aug; 28(4):459-71. PubMed ID: 17764063
[TBL] [Abstract][Full Text] [Related]
15. Drug insight: rituximab in renal disease and transplantation.
Salama AD; Pusey CD
Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
[TBL] [Abstract][Full Text] [Related]
16. Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.
De Marchi G; De Vita S; Fabris M; Scott CA; Ferraccioli G
Haematologica; 2004 Apr; 89(4):ECR03. PubMed ID: 15075095
[TBL] [Abstract][Full Text] [Related]
17. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.
Strauss SJ; Morschhauser F; Rech J; Repp R; Solal-Celigny P; Zinzani PL; Engert A; Coiffier B; Hoelzer DF; Wegener WA; Teoh NK; Goldenberg DM; Lister TA
J Clin Oncol; 2006 Aug; 24(24):3880-6. PubMed ID: 16864854
[TBL] [Abstract][Full Text] [Related]
20. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
